New hope for kids with rare blood diseases through safer stem cell transplants
NCT ID NCT06731036
Summary
This program provides expanded access to a special machine that filters stem cells before a transplant. The goal is to reduce a dangerous side effect called graft-versus-host disease (GVHD) by removing certain immune cells. It is for patients, including children over 1 month old, with conditions like severe combined immunodeficiency, sickle cell disease, and Fanconi anemia who are receiving a stem cell transplant.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SICKLE CELL DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.